Lv11
58 积分 2025-01-27 加入
Systematic analysis of the potential off-target activities of osimertinib by computational target fishing
1个月前
已完结
Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma
2个月前
已完结
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
3个月前
已完结
Combination BRAFV600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAFV600E-Mutant Anaplastic Thyroid Cancer
3个月前
已完结
BRAFV600E/ p-ERK/ p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer
4个月前
已完结
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma
4个月前
已完结
皖公网安备34019202002308
